In a wide-ranging look at how exponential technologies could change the face of healthcare, Daniel Kraft, Faculty Chair of Medicine and Neuroscience at Singularity University, told Techonomy 2018 attendees Sunday that personalized medicine is on our doorstep, from wearables to "printed" medications. More
Bio & Life Sciences Healthcare
A new study makes the case that genomic medicine can be cost effective in diagnosing rare diseases, offering a potential alternative path for millions of patients worldwide. More
Resistance from insurance companies threatens to slow innovation that could dramatically improve patient outcomes from genomic testing. More
Twenty years of investment in biomedical infrastructure and innovation is starting to pay off for Singapore. More
Bio & Life Sciences Healthcare
A new report suggests that an innovative method of analyzing DNA will allow medical researchers to predict disease risk for far more people than can be done with conventional medical tests. More
Bio & Life Sciences Healthcare Opinion
In which our intrepid reporter gives her very blood to stay on the front lines of modern healthcare. More
The growing number of cancer patients in Asia is spurring innovative research and development — and some promising diagnostic developments. More
The design and execution of clinical trials represents an ideal opportunity to engage the consumer and begin building a relationship that can last a lifetime. More
Bio & Life Sciences Healthcare
New studies connect gene editing with CRISPR technology to cancer, sending stocks plummeting and raising serious questions about the technology's potential. More
In the wake of the Facebook data breach, consumer concerns over data security could slow the growth of digital health. Blockchain may be a solution. More
There are an estimated 7,000 rare diseases known today, collectively affecting some 350 million people around the world. Big data, AI, and smart records bring hope. More
As genomic testing becomes more popular, it is outstripping the industry's ability to provide experts to interpret the results. The shortage of trained counselors highlights a paradox — rapid adoption can be just as big of a threat to the future of the field as too slow adoption. More
Community Insights Healthcare Innovation
Wearable technologies have the potential to revolutionize health care—but to reap the benefits devices need to be more accurate, doctors need to be more receptive to using the data, and systems need to be deeply integrated. More
Community Insights Healthcare Science
Consumer DNA testing has great consumer appeal, but a nuanced understanding of how to put findings into context has been lost in some of the hype. More
Japan is one of the oldest societies on earth-over 25 percent of its citizens are over 65-and most project that it will continue to age rapidly in the coming decades. As a result, MedTech entrepreneurs are developing innovative medical technologies designed specifically for eldercare. More
Community Insights Healthcare Innovation
The tech world is often quick to dismiss "traditional" healthcare as slow. But to push the sorely needed transformation within healthcare, technology players and today's healthcare stakeholders will have to collaborate. More
Bio & Life Sciences Healthcare Science
During the next two years, NHGRI will be using interactions with scientists and the public to take stock of the genomics field and where its funds can make the most difference. The landscape has shifted rapidly from the institute's early days, when it set the direction for much of the genomics community around the world. More
At the recent HealthTechO2O conference in Hong Kong, it was clear that Hong Kong has the potential to be a healthcare innovation hub — but that it still has a long way to go to fulfilling that potential. More
Healthcare Innovation Partner Insights
As the healthcare industry moves away from "sick care" to prevention and healthy living, a new level of collaboration between health systems is needed, says Philips North America CEO. (Note: Philips is a Techonomy partner.) More
CVS agreed Sunday to buy Aetna for about $69 billion. Just a month ago, Aetna CEO Mark Bertolini recently sat down with David Kirkpatrick onstage at Techonomy 2017 and shared his vision for a new kind of in-store experience for healthcare. More
Newsletter
